NCT05607199View on ClinicalTrials.gov

A First in Human Study of AUR 103 Calcium to Evaluate Safety, Pharmacokinetics and Pharmacodynamics

PHASE1RecruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

September 16, 2022

Primary Completion Date

September 16, 2025

Study Completion Date

October 16, 2026

Conditions
Solid Tumor, AdultAcute Myeloid LeukemiaMyelodysplastic SyndromesNon Hodgkin Lymphoma
Interventions
DRUG

AUR103

Twice Daily

Trial Locations (5)

10029

RECRUITING

All India Institute of Medical Sciences, Delhi

395002

RECRUITING

Unique Hospital, Surat

395004

RECRUITING

Kiran Multi Super Specialty Hospital, Surat

411001

RECRUITING

Grant Medical Foundation Ruby Hall Clinic, Pune

570001

RECRUITING

K R Hospital, Mysore

Sponsors
All Listed Sponsors
lead

Aurigene Discovery Technologies Limited

INDUSTRY